## Background: African-american patients have been under-represented in oncology clinical trials. better understanding barriers to african-american participation may help increase the accrual of african-american patients onto clinical trials. ## Methods: Two hundred eighteen patients with maligna
Diversity of participants in clinical trials in an academic medical center : The role of the ‘Good Study Patient?’
✍ Scribed by Galen Joseph; Daniel Dohan
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 100 KB
- Volume
- 115
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## How Do We Improve the Quality of Clinical Trials in Japan? The Role of the Medical Doctor In recent years, a lot of focus has been on the quality of clinical trials in Japan. The implementation of the new Good Clinical Practice (GCP), harmonized with international standards, has prompted drug c
## Background: The unsatisfactory control of neuroendocrine tumor growth with chemotherapy and/or interferon (ifn-2a) stimulated us to investigate the role of the somatostatin analogue octreotide (sms 201.995), which is reported to be highly effective in controlling carcinoid syndrome symptoms. oct
This paper describes the demographic experience on 373 young cancer patients (less than 20 years of age) at two oncology centers initiated in Israel by one medical team in 1975-1977. These units are the Assaf Harofeh Medical Center (AHMC), which predominantly serves a Jewish population (103 cases);